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L angerhans cells (LC) belong to the family of antigen-presenting dendritic cells [1] and represent an outpost of the immune system in the skin and in other epithelia, e.g., nasal mucosa or the lung. Initially, only receptors for the Fc fragment of IgG had been demonstrated on 
LC [2,3], until Bruynzeel-Koomen et al reported the presence of 
IgE molecules on epidermal Langerhans cells (LC) in patients with 
atopic dermatitis [4J. This observation led to an attractive concept of 
the pathophysiology of this disease in which LC would act as a link 
between type I and type IV reactions. Since then, further studies 
have contributed to better define the conditions under which IgE-
bearing LC are present in the skin. These may be summarized as 
follows: a) normal human LC are able to bind IgE [5,6], and b) the 
presence of IgE-bearing LC in a skin area of a patient with elevated 
IgE levels is linked to a mild inflammation located in this area [7] . 
Although IgE-bearing LC are not specific for atopic disease [8], this 
does not preclude a specific role for LC in the genesis of AD. Thus, 
important factors need to be considered such as a) the specificity of 
IgE molecules on LC and b) the increased transepidermal penetra-
tion of allergens due to an altered epidermal barrier function. Char-
acterization of the IgE-binding structure(s) expressed on LC has 
enabled a greater understanding of the putative involvement of LC 
in the pathophysiologic events of atopic dermatitis (AD). 
Recently, the presence of three distinct IgE-binding structures on 
LC was demonstrated, i.e., the low-affinity receptor for IgE 
FCERIIjCD23 [9,10], the so-called IgE-binding protein EBP 
(which is the human analogue of the murine Mac-2 antigen) [11] 
and, most surprisingly, the high-affinity receptor for IgE FCERI 
[12] . 
FCERI IS CONSTITUTIVELY EXPRESSED ON 
RESIDENT HUMAN LANGERHANS CELLS 
Initially, studies of the characteristics of the IgE-binding structures 
present on LC isolated from patients with AD [13] revealed that 
they are trypsin resistant and display affinity for IgE and to a lesser 
extent for IgG. More recently, using human IgE myeloma protein, 
we and others were able to demonstrate that normal human LC bind 
IgE molecules in situ as well as in vitro [5,6] . This IgE binding was 
not inhibited by anti-FcERIIjCD23, anti-EBP, or anti-FcyR re-
agents, suggesting that normal LC exhibit a distinct IgE-binding 
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structure, which is in fact responsible for the greater part of their 
IgE-binding capacity [6] . 
Thus we investigated LC for the putative presence of the high-
affinity receptor for IgE, FCERI, which is composed of a tetramer of 
an a-subunit (FcERla), a p-subunit (FCERIP), and two y-subunits 
(FCERly), which had thus far been described only on mast cells and 
basophils (most aspects of FCERI are reviewed in [14]). Using a 
molecular biology approach with reverse transcription and polym-
erase chain reaction (RT -PCR) with primers specific for the sub-
units of FCERI and total RNA from highly purified human LC, we 
were able to amplify cDNA fragments identical to those obtained by 
RT-PCR from human peripheral blood basophils and leukemic 
basophils KU812 used as controls. The specificity of these PCR 
fragments was confirmed by restriction enzyme analysis and South-
ern hybridization. Furthermore, cDNA from the as yet unreported 
p-chain of human basophils and LC was isolated, cloned, and se-
quenced, revealing 70% homology with the p-chain of the mouse 
FCERI. Contamination of LC with mast cells or basophils was for-
mally excluded because we could not detect by RT -PCR the mRNA 
for tryptase, an enzyme which is only expressed in mast cells and 
basophils. This clearly showed that human LC express mRNA tran-
scripts coding for the three polypeptides of FCERI. 
Recently, a series of anti-FceRla monoclonal antibodies were 
raised from mice immunized with a purified chimeric FCERIa ex-
pressed in Chinese hamster ovarian cells [15]. Using two of these 
reagents, the anti-FcERla antibodies 6F7 and 29C6, we could detect 
reactivity not only on dermal mast cells but also on some dermal 
dendritic cells and most importantly on dendritic cells in a supraba-
sal region of the epidermis. Double-labeling experiments and flow-
cytometric analysis, performed on freshly isolated LC-enriched epi-
dermal cell suspensions using anti-FcERla and anti-CDla reagents, 
clearly demonstrated that in the epidermis FCERI is exclusively ex-
pressed on LC. Biochemical characterization of the anti-FcERla 
reactive structure by immunoblot analysis of lysates from purified 
LC revealed a structure of apparent molecular weight of 50 kDa, 
consistent with the a-subunit of FcERl. This provided proof that 
translation and protein surface expression of mRNA for FCERI 
occur in normal human LC. 
In view of the profound phenotypic and functional alterations 
occurring during culture of LC, the fate of FCERI expression on LC 
in vitro was investigated. Preliminary experiments have suggested 
that.a) expression ofFcERI on LC is rapidly downregulated in vitro, 
leadmg to a loss of the IgE-binding capacity in cultured LC; b) this 
observation correlates with a rapid disappearance of mRNA tran-
scripts for at least the a and y subunits of FCERI; and c) among 
s~veral cyto~ine~ tested for their ab~lity to influence FCERI expres-
SIon on LC m VItro, only IL-3, wluch has a similar effect on baso-
phils, mast cells, and their precursors [16] , partially and inconsist-
ently maintains the IgE-binding capacity of cultured LC. 
Therefore, FCERI expression cannot be considered as a stable marker 
of human LC. 
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POSSIBLE FUNCTIONAL SIGNIFICANCE 
OF FCERI ON LC 
Th cellular mechanisms triggered by IgE binding to cell mem-
e receptors and/or allergen binding to IgE, which leads to 
branelinking of IgE, depend on the interaction of the latter with 
croSS . 1 f . I d h £ 
. fic receptors, 1.e., t le type 0 receptors InVO ve on t e sur ace 
sIfectrector cells. Crosslinking of FCERI-bound IgE-molecules on 
o et cells and basophils results in the release of mediators of ana-
rn:s laxis [17]. Because LC are devoid of th~se mediators: crosslin~­
p y fFcERI unlike in mast cells and basophtls cannot be Involved In I~~ ~apid exocytosis of such substances. However, it has recently 
~ me evident that mast cells also represent a potent source of a e~O of cytokines that may profoundly affect the immune system 
senes . chi f h b . ·11 
[18]. The exact mechamsm lor t. e r~ ease 0 t ese ~u s~ances IS Stl I ar and may be linked to activation processes dlffenng from the 
uln
c ~cal crosslinking of FCERI. In the case of FCERI on LC, only 
c aSSI . I b I· I . k b I lation is posslb e, ecause Itt e IS nown a out t le secretory 
speCUtoire of this dendritic cell (see other papers in this issue). Never-
[hePler s it is possible that such crosslinking of FCERI on LC could 
tees , f h . fl d· h I d to the release by LC 0 ot er m ammatory me lators suc as ;~F-a or of substan~es che~otactic for mononuclear cells and/or 
T cells at the site of mteractlon. 
o the other hand, because the presence ofIgE or IgG molecules 
B
n 
cells confers on these cells the capacity of antigen focusing 
on . ·1 fi 
[19], it is possible that Ig rec~ptors on LC may sez:ve a SimI ar. unc-
. Thus the unique capacIty ofLC to provIde SIgnals for pnmary 
uon . , I d b I d econdary immune responses may be comp emente y t le ~n fvement of FCERI in antigen uptake and processing. Although ~~o re not able to phagocytose, FCERI loaded with specific IgE 
aid allow them to capture antigens of relatively high molecular 
wou d d . P . 
. ht and to initiate IgE- epen ent Immune responses. revlous 
wedl!? es based on IgE-bearing LC isolated from atopic skin and auto-
stU I d I·· I fi lb · I us T cells [20] an pre Immary resu ts rom our a oratory uSing O~?gen-specific T-cell clones support this concept. Furthermore, a~ 1 FCERI expression is rapidly downregulated in LC upon isola-Since . . I · I b·l · k . 
. one might antiCIpate a oss 111 t le a I Ity to ta e up antigens 
non, LC have started to differentiate and migrate to the regional once 
lymph nodes . 
CONCLUSION 
The finding of FCERI on LC. docum~nts the end of a dogma that 
(pulated that this structure IS exclUSIvely expressed on mast cells ~~d basophils [14]. On the ?ther hand, it opens new 'persp~cti~es 
. th regard to the immunoblOlogy ofLC and the functlona.1 slgl11fi-
WI ce of FCERI on antigen-presenting cells or cells lack111g pre-f~~med mediators like hi~tamine or serotonin. Furthermore, this 
bservation al ters the claSSIcal concept of Gell and Coombs, accord-
? to which IgE-mediated immediate reactions may be clearly sepa-1l1~ed from the delayed cellular type hypersensitivity. Finally, con-r~dering the phylogenic significance of IgE antibodies [21] and the f~ct that LC express all th.ree IgE-binding structures so far charac-
terized in the human Immune system, we should prob~bly 
reconsider the natural role of LC and include def~nse mechamsms 
gainst parasites and triggering of immune reactions to allergens 
feading to IgE synthesis. A greater unders~andi.ng ~f cel.lular ev~nts 
linked to the binding ofIgE to LC and theIr activatIOn vIa cross)mk-
ing by allergens mar pr.ovide .the basis ~or .new therapeutic and/or 
prophylactic strategIes 111 whIch IgE-b111dll~g structures on LC or 
related dendritic cells could represent putative targets. 
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